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ABSTRACT
Objectives: The aim of the study was to compare Insulin-like Growth Factor-1 (IGF-1)concentration in pregnancies com-
plicated by pregnancy-induced hypertension and/or intrauterine hypotrophy, and its correlation with maternal pressure 
and umbilical artery pulsatility and resistance indices. 
Material and methods: 65 pairs pregnant-newborn were included to four groups: I — control, II — PIH, III — Hypotrophy, 
IV — PIH and Hypotrophy. In the study we analyzed cord blood IGF-1 concentration, newborns antropometry, umbilical 
artery pulsatility and resistance indices and maternal pressure before delivery. 
Results: The concentration of IGF-1 was the lowest in IV group of hypotrophic newborns from pregnancies complicated 
by pregnancy-induced hypertension. In this group of patients there was strong negative correlation between IGF-1 con-
centration and maternal systolic and diastolic pressure. 
Conclusions: There is a strong negative correlation between IGF-1 concentration and maternal systolic pressure in group 
of hypotrophic newborns from pregnancies complicated by pregnancy-induced hypertension.
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INTRODUCTION
Pregnancy induced hypertension (PIH) is one of the most 
serious complication of pregnancy significantly increasing 
the risk of stillbirth, prematurity, and perinatal death, both 
maternal and neonatal. Coexistence of pregnancy induced 
hypertension with intrauterine fetal hypotrophy increases 
these risks [1], but also has long-term negative impact on 
the further development of the children [2].
It is estimated that PIH occurs with varying intensity 
in 5–8% of all pregnancies [3], and their etiology is mul-
tifactorial and still unclear. It is believed that the basis for 
the development of this pathology are abnormal differen-
tiation and invasion of extravillous trophoblast cells [4]. In 
healthy developing placentas, the extravillous trophoblast 
cells infiltrate spiral arteries, undergoing transformation 
from an epithelial to an endothelial phenotype. This leads 
to remodeling of their walls, conversion of muscles and 
elastic tissue localized in tunica media to fibrinous tissue. 
This process consists of two phases and enables transforma-
tion of these high resistance arteries into high capacitance, 
easily responsive to increased blood flow utero-placental 
vessels. The first stage includes the migration of trophoblast 
cells into the decidua. In the second stage, lasting from the 
15th to 20th week of gestation, trophoblast cells infiltrate 
the spiral arteries. Abnormalities of the second phase was 
histologicaly observed in placentas from pregnancies com-
plicated by PIH, especially incomplete transformation of 
spiral arteries. This pathology can result in high resistance 
in placental vessels, significantly reducing placental blood 
flow. Impaired placental perfusion leads to fetal growth 
retardation, activation of inflammatory response cascade 
and damaging of endothelium [5, 6].
Intrauterine growth restriction occuring before the 32nd 
week of gestation (early onset IUGR) is more often associ-
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ated with serious structural and functional abnormalities of 
the placenta, increased resistance in the placental vessels, 
haemodynamic changes with circulatory redistribution, and 
in the most severe cases centralization of fetal circulation. 
This form of IUGR is in 35% associated with pregnancy-
-induced hypertension [7].
Umbilical arteries pulsatility and resistance indices are 
good parameters of fetal well-being status. Studies have 
also shown that screening doppler velocimetry between 
20–24 weeks of gestation are good prognostic factors in 
assessing the risk of developing pregnancy-induced hyper-
tension and intrauterine growth retardation [8].
Objectives
The aim of this study was a comparative analysis of 
IGF-1 concentrations in cord blood in three clinical situa-
tions : 1. In pregnancies complicated by pregnancy-induced 
hypertension (PIH) and intrauterine fetal hypotrophy. 2. In 
pregnancies complicated by PIH, with normal intrauterine 
growth of the fetus. 3. In pregnancies complicated by intrau-
terine fetal hypotrophy, without pregnancy-induced hyper-
tension. An attempt was also made to assess the correlation 
between values of the pulsatility and resistance indices 
in umbilical arteries and maternal blood pressure on the 
concentration of insulin-like growth factor-1 in cord blood.
MATERIAL AND METHODS
In this study 65 pairs, pregnant-newborn, hospitalized 
in the Department of Gynecology and Obstetrics of the 
Specialist Hospital No. 2 in Bytom between 2015–2018 were 
assessed.
The pairs were included to one of four groups depend-
ing on the clinical situation:
•	 Control — eutrophic newborns from uncomplicated 
pregnancies;
•	 PIH — eutrophic newborns from pregnancies compli-
cated by Pregnancy-Induced Hypertension;
•	 Hypo — Hypotrophic newborns from uncomplicated 
pregnancies;
•	 PIH+Hypo — hypotrophic newborns from pregnancies 
complicated by Pregnancy-Induced Hypertension.
Exclusion criteria:
•	 prematurity < 32. weeks of gestation;
•	 multiple pregnancy;
•	 maternal diabetes;
•	 congenital diseases (including congenital defects, infec-
tions, persistent pulmonary hypertension);
•	 chronic maternal hypertension.
In all groups, the concentration of Insulin-like growth 
factor-1 (IGF-1) in the umbilical cord blood was tested by 
an immunoenzymatic method — ELISA with the use of 
Human IGF-1 Elisa Kit. The obtained results were analyzed 
in relation to mean values of systolic and diastolic blood 
pressure evaluated in the last day before pregnancy termina-
tion, pulsation index value and resistance index in umbilical 
arteries, based on routine pre-natal ultrasound examina-
tion with Color Doppler option. Neonatal anthropometric 
parameters (body length, birth weight, head circumference, 
chest circumference) were also analyzed.
Statistical analysis of the collected research material 
was based on the STATISTIKA statistical package, version 
9.4. Distribution of quantitative variables was characterized 
by the mean and median values, standard deviation and 
standard error. The conformity assessment of the distribu-
tion of quantitative variables with normal distribution was 
performed using the Shapiro-Wilk test. Statistical signifi-
cance of differences in distributions of quantitative variables 
between research groups was carried out using analysis of 
variance (ANOVA), with the assumption of homogeneity 
variations, whereas in the case where the variable distribu-
tion deviate from the normal, or in case of failure assumption 
of homogeneity of variance, Kruskal-Wallis and non-para-
metric U Mann-Whitney test was applied. Simple analysis 
was summarized multivariate regression analyzes. Statistical 
inference is based on the criterion of statistical significance 
of α = 0.05.
RESULTS
Based on the analysis, it was observed that the con-
centration of insulin-like growth factor-1 was the lowest 
in the group of hypotrophic newborns from pregnancies 
complicated by pregnancy-induced hypertension and 
was significantly lower compared to eutrophic newborns 
from normal pregnancies and pregnancies complicated 
by pregnancy-induced hypertension. In the groups with 
isolated hypotrophy or pregnancy-induced hypertension, 
IGF-1 concentrations were also lower than in healthy new-
borns, but without statistical significance (Fig. 1). 
Figure 1. Comparative analysis of mean concentration of IGF-1 
in cord blood in study groups with standard error and the 95% 
confidence interval
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The groups also differed in the values of anthropometric 
measurements, birth weight, body length, head circumfer-
ence and chest circumference. These parameters were, of 
course, significantly lower in hypotrophic neonatal groups 
with or without gestational-induced hypertension. There 
was also a tendency to lower values of these parameters in 
newborns from the PIH group relative to the control group 
but no statistical significance was found. It may indicate 
some risks in this group of patients in which pre-natally no 
intrauterine growth inhibition was observed. Regression 
analysis showed a strong negative correlation between 
systolic blood pressure and the concentration of insulin-like 
growth factor-1 in the hypotrophic neonatal population 
from pregnancies complicated by pregnancy-induced hy-
pertension (Tab. 1). A similar tendency was observed in the 
group of eutrophic neonates from pregnancies with PIH, 
although without statistical significance. Interestingly, there 
seem to be differences between groups of newborns with 
pregnancies complicated by pregnancy-induced hyperten-
sion and isolated hypotrophy. In the group of isolated hypo-
trophy we observed possitive correlation between values 
of pulsatility and resistance indices and concentrations of 
IGF-1. We also observed surprisingly positive correlation be-
tween antropometric parameters and systolic and diastolic 
maternal pressure, but there was no correlation between the 
head circumference and body length and the concentration 
of insulin-like growth factor-1 in cord blood in this group 
of patients. In the remaining groups, lower concentrations 
of IGF-1 were observed with the increase of the pulsatility 
and resistance indices. In the PIH and PIH + Hypo groups, 
higher values of birth weight and body length, head and 
chest circumference were observed with an increase in 
IGF-1 concentration (Tab. 2).
DISCUSSION
Insulin-like growth factors (IGF-1 and IGF-2) are peptides 
with structural similarity to proinsulin. The biological role of 
insulin-like growth factor-1 is omni-directional, with both 
aut-, para- and endocrine regulation. Its presence is already 
observed in the early stages of embryonic development 
and is one of the most important factors of growth, differ-
entiation and maturation of tissues, affecting fetal growth 
processes. It also seems to be an extremely important factor, 
in addition to vascular endothelial growth factor (VEGF), 
Progesterone induced blocking factor (PIBF) and insulin-like 
Table 1. Patients characteristics — median values with the lowest and the highest values and standard deviations in parentheses
Control PIH Hypo PIH + Hypo
N 25 14 16 10
Maternal age 30 (6) 34 (5) 34 (6) 33 (4)
Maternal BMI [kg/m^2] 28.8 (4.4) 35.3 (4.6) 29.5 (4.5) 30.3 (6.47)
Maternal Weight [kg] 78.5 (12.9) 95.2 (14.7) 77.4 (13.2) 86.7 (16)
Hbd 37 (34–41) 36 (32–41) 37 (34–40) 34 CTR, H (32–41)
B.W. [g] 3190 (2170–4480; 492.5) 2870 (1960–3800; 580) 2257 CTR, P (1600–2900; 352) 1550 CTR,P (840–2920; 562)
Lenght [cm] 53.1 (47–60; 2.5) 52.5 (47–60; 4.0) 49 CTR (43–54; 3) 43.0 CTR,P (35–55; 5.2)
Head circ. [cm] 35 (31–38; 2) 34 (30–37; 2) 32.0 CTR (30–34; 1) 29.0 CTR, P (24–32; 2.2)
Chest circ.[cm] 33 (29–37; 2) 31 (27–34; 2) 29.0 CTR, P (26–33; 2) 25.0 CTR, P (20–32; 3.4)
PI in UA 0.86 (0.52–1.26; 0.17) 0.86 (0.55–1.18; 0.20) 0.90 (0.63–1.44; 0.24) 1.1 (0.81–1.9; 0.32)
RI in UA 0.57 (0.39–0.75; 0.08) 0.56 (0.40–0.68; 0.08) 0.59 (0.46–0.79; 0.09) 0.70 CTR (0.55–1.00; 0.14)
Sys. Pressure 109 (82–132; 12) 139 (109–178; 24) 124 (105–145; 14) 160 CTR, P, H (118–249; 36)
Dia. Pressure 68 (50–90; 9) 88 (72–103; 11) 76 (49–92; 11) 98 CTR, P, H (70–149; 21)
IGF-1 (IU/l) 10.9 (2.02–38.3; 6.4) 7.50 P+H (3.28–16.81; 3.74) 5,9 (2.44–19.96; 4.62) 3,4 CTR, P (2.28–11.21; 2.70)
P; H; P+H; CTR — statistical significance comparing to group (respectively): PIH, Hypo, PIH + Hypo and Control (p value < 0.05)
Table 2. Correlation between the concentration of insulin-like 
growth factor-1 in cord blood and selected parameters in the tested 
and control groups
Control PIH Hypo PIH + HYPO
HBD 0 0.28 0 0.24
B.W [g] 0 0.44 –0.31 0.30
Lenght –0.21 0.39 0 0.41
Head circ. [cm] –0.21 0.16 0 0.18
Chest circ. [cm] 0 0.37 –0.43 0.35
Sys. Pressure [mm Hg] 0 –0.24 0 –0.81#
Dia. Pressure [mm Hg] 0 –0.20 0 –0.63
Mean UA PI –0.27 –0.42 0.20 –0.47
Mean UA RI –0.24 –0.32 0.27 –0.64
# means statistical significance (p < 0.05)
547
Patrycja K. Gazy et al., The concentration of insulin-like growth factor-1 in pregnancies complicated by pregnancy-induced hypertension
www. journals.viamedica.pl/ginekologia_polska
growth factor-2, which determines normal course of matura-
tion, differentiation and invasion of extravillous trophoblast 
in spiral arteries, which process, if it goes wrong, is consid-
ered the main cause of pregnancy-induced hypertension [9]. 
The studies also demonstrated the regulatory effect of 
IGF-1 on endothelial function. It regulates and stimulates the 
migration of endometrial cells, stimulates neovasculariza-
tion processes. There are also reports of IGF-1 vasodilatation 
function in in vivo studies [10]. In animal model studies, low 
concentrations of IGF-1 were found to be associated with 
higher blood pressure values  due to impaired endothe-
lium-dependent vascular relaxation via nitric oxide and 
increased expression of vasoconstrictor endothelin [11]. In 
vitro studies on endothelial cells of human umbilical veins 
showed a strong effect of insulin and IGF-1 on the synthesis 
of nitric oxide [12]. It is believed that one of the mechanisms 
of pregnancy-induced hypertension is the disturbed bal-
ance between vasodilators and vasoconstrictors. It is also 
known that insulin resistance is one of the important risk 
factor for pregnancy-induced hypertension.
In pregnancies complicated by preeclampsia, a lower 
IGF-1 concentration was observed as compared to preg-
nancies with normal maternal blood pressure [13, 14], and 
the severity of preeclampsia was inversely correlated with 
IGF-1 expression in the placenta and was in direct propor-
tion to expression of Insulin-like growth factors binding 
protein-3 [15].
In the present study, similar results were also observed 
with lower IGF-1 concentrations in pregnancies complicated 
by pregnancy-induced hypotension and/or hypotrophy 
compared to the control group. Only in groups with preg-
nancy-induced hypertension concentration of IGF-1 was 
negatively correlated with maternal arterial pressure and 
resistance and pulsatility indices in umbilical arteries.
The limitation of this study was lower mean gestational 
age in groups of isolated PIH and PIH with hypotrophy 
compared with the other groups. It resulted from the ne-
cessity to terminate such a complicated pregnancy earlier, 
both due to the mother’s condition (preeclampsia, placental 
abruption) and threatening fetal asphyxia, which was the 
most common cause. 
However, in the statistical analysis, there was no sig-
nificant relationship between IGF-1 concentration and 
gestational age. Similar results were published by S. Sifakis 
et al. [16]. They did not show statistically significant correla-
tions between gestational age, pulsatility index values in the 
umbilical arteries and IGF-1 concentration.
The other limitation of this study was the lack of informa-
tion about biochemical profiles and uterine artery flow in 
the first trimester. Other limitations included the presence 
of PIH and/or IUGR in previous pregnancies and the usage 
of acetylsalicylic acid as a prophylaxis of preeclampsia.
Incorrect placental formation leads to its insufficiency, inad-
equate supply of nutrients to the fetus and, as a result, to fetal 
growth restriction. These unfavorable intrauterine conditions 
result in limitations of cell divisions, changes in metabolic and 
signaling pathways, and even lead to epigenetic changes. This 
phenomenon was discribed as Barker’s hypothesis [17].
An extremely important role in these processes plays 
reduced insulin secretion, as well as disturbances in the 
Growth Hormone/IGF-1 axis. The animal model studies have 
shown a reduction of pancreatic B-cells mass in growth 
restricted fetuses [18–20]. An animal model presented by 
Jones et al. in 1984 showed significant endocrine differences 
between eutrophic and hypotrophic fetuses. In smaller ges-
tational age fetuses (SGA) they observed hypoglycaemia, 
hypoinsulinaemia, hypocortyzolemia and hypothyreosis, 
and they were negatively correlated with severity of growth 
restriction. In the SGA group there was also higher secretion 
of androstenedione and glucagon [21]. The studies also 
showed significantly lower insulin-like growth factor-1 se-
cretion and increased insulin-like growth factor-2 secretion 
compared to normal growing fetuses [22]. 
SUMMARY
Pregnancy-induced hypertension is strongly associated 
with the risk of IUGR, and insulin-like growth factor-1 seems 
to be a common denominator in the pathomechanism of 
these pregnancy complications, both independently and co-
existing. An extremely interesting issue is the increased risk 
of hypotrophy in the normotensive pregnancy of mothers 
with history of pregnancy-induced hypertension in previ-
ous pregnancies. This phenomenon has not been explained 
yet, but it has been confirmed in a large cohort study on the 
Swedish population, which may indicate a common molecular 
mechanism of both complications of pregnancy [23]. Based 
on this study it seems that in the case of pregnancy-induced 
hypertension, the concentrations of insulin-like growth fac-
tor-1 are lower with the higher values of maternal systolic 
and diastolic pressures and pulsatility and resistance indices 
in umbilical arteries. However, in the case of isolated hypotro-
phy, despite lower cord IGF-1 concentrations, there was no 
correlation between maternal blood pressure and IGF-1 con-
centration. Interestingly, during the study we observed that in 
the hypotrophy group the IGF-1 concentration was discretely 
higher at higher values of the umbilical artery resistance and 
pulsatility indices, which may suggest a completely different 
pathomechanism. Therefore, it is necessary to broaden the 
research in this field with the comparison of this two serious 
complications of pregnancy.
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